Allianz Asset Management
OCDX

Allianz Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Allianz Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,078
Closed -$300K – 2515
2022
Q1 		$300K Sell
16,078
-12,014
-43% -$216K ﹤0.01% 2223
2021
Q4 		$601K Buy
28,092
+7,794
+38% +$154K ﹤0.01% 2130
2021
Q3 		$375K Buy
20,298
+265
+1% +$5.34K ﹤0.01% 2341
2021
Q2 		$429K Buy
+20,033
New +$407K ﹤0.01% 2111

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allianz Asset Management's OCDX Position: Q2 2022 in Review

Allianz Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 16,078 shares — an estimated $300K sold.

Allianz Asset Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $601K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Allianz Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Allianz Asset Management sold 16,078 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $300K.
  • Allianz Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • Allianz Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $601K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Allianz Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.